Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapy.
Wang R, Wang B, Zhang H, Liao X, Shi B, Zhou Y, Zhou C, Yan Y, Zhang W, Wang K, Ge G, Ren Y, Tang X, Gan B, He J, Niu L.
Wang R, et al. Among authors: wang k, wang b.
Breast. 2024 Apr 24;76:103738. doi: 10.1016/j.breast.2024.103738. Online ahead of print.
Breast. 2024.
PMID: 38685149
Free PMC article.